Cancer, HIV and hemophilia medicines are among the most counterfeited medical products in Argentina. Counterfeiters have moved from lifestyle drugs to counterfeiting life-saving medicines, putting the health and safety of unsuspecting consumers at risk.
Reports like these highlight the need to keep the U.S. medicine supply chain closed and protected. Vigilance keeps the global counterfeit medicine problem largely outside our borders. However, proposed drug importation legislation could inadvertently open our borders to counterfeit imported medicine, potentially threatening the safety of our drug supply.